Tag: Type 2 Diabetes
Eli Lilly’s promising new obesity drug, retatrutide, just passed its first late-stage diabetes trial.
Imagine a future where managing chronic conditions like obesity and type 2 diabetes isn't a relentless uphill battle, but a journey made significantly smoother...
Ozempic launches in India as Novo Nordisk sharpens its GLP-1 push
In a significant development for diabetes management in India, Novo Nordisk has officially launched Ozempic (semaglutide) in the country. This eagerly anticipated introduction marks...
